Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma

International Immunopharmacology

Volumn 17, Issue 3, 2013, Pages 867-873

  Shin, In Sik ^a   Jeon, Woo Young ^a   Shin, Hyeun Kyoo ^a   Lee, Mee Young ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Chronic asthma; Pulmonary fibrosis; Samd3; Transforming growth factor; Vascular endothelial growth factor

Indexed keywords

EOTAXIN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; MONTELUKAST; OVALBUMIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; LUNG PARENCHYMA; MOUSE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH2 CELL; TREATMENT DURATION; WESTERN BLOTTING;

CHRONIC ASTHMA; PULMONARY FIBROSIS; SAMD3; TRANSFORMING GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ACETATES; ALLERGENS; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN E; LEUKOTRIENE ANTAGONISTS; LUNG; MICE; MICE, INBRED BALB C; MUCUS; OVALBUMIN; PULMONARY FIBROSIS; QUINOLINES; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885739543     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.09.017     Document Type: Article

References (35)

1. U. Mabalirajan, J. Aich, A. Agrawal, and B. Ghosh Mepacrine inhibits subepithelial fibrosis by reducing the expression of arginase and TGF-beta1 in an extended subacute mouse model of allergic asthma Am J Physiol Lung Cell Mol Physiol 297 2009 411 419
2. M.Y. Lee, J.A. Lee, C.S. Seo, H. Ha, N.H. Lee, and H.K. Shin Protective effects of Mentha haplocalyx ethanol extract (MH) in a mouse model of allergic asthma Phytother Res 25 2011 863 869
3. K.S. Lee, S.R. Kim, H.S. Park, K.H. Min, K.Y. Lee, and S.M. Jin Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice J Allergy Clin Immunol 119 2007 141 149 (Pubitemid 46037801)
4. N.I. Chaudhary, G.J. Roth, F. Hilberg, J. Muller-Quernheim, A. Prasse, and G. Zissel Inhibition of PDGF, VEGF and FGF signaling attenuates fibrosis Eur Respir J 29 2007 976 985 (Pubitemid 46711904)
5. K.S. Lee, S.J. Park, S.R. Kim, K.H. Min, K.Y. Lee, and Y.H. Choe Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signaling pathway Eur Respir J 31 2008 523 531
6. C.G. Lee, H. Link, P. Baluk, R.J. Homer, S. Chapoval, and V. Bhandari Vascular endothelial growth factor (VEGF) induces remodeling and enhances Th2-mediated sensitization and inflammation in the lung Nat Med 10 2004 1095 1103 (Pubitemid 39424871)
7. L.M. Vasquez-Pinto, F. Nantel, P. Sirois, and S. Jancar Bradykinin B(1) receptor antagonist R954 inhibits eosinophil activation/proliferation/migration and increases TGF-beta and VEGF in a murine model of asthma Neuropeptides 44 2010 107 113
8. J. Mullol, F.B. Callejas, E. Mendez-Arancibia, M. Fuentes, I. Alobid, and A. Martinez-Anton Montelukast reduces eosinophilic inflammation by inhibiting both epithelial cell cytokine secretion (GM-CSF, IL-6, IL-8) and eosinophil survival J Biol Regul Homeost Agents 24 2010 403 411
9. C. Shimbori, N. Shiota, and H. Okunishi Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice Eur J Pharmacol 650 2011 424 430
10. H. Yoshisue, J. Kirkham-Brown, E. Healy, S.T. Holgate, A.P. Sampson, and D.E. Davies Cysteinyl leukotrienes synergize with growth factors to induce proliferation of human bronchial fibroblast J Allergy Clin Immunol 119 2007 132 140 (Pubitemid 46037796)
11. H.S. Yang, L. Wang, W. Yang, J.Y. Guan, and Y. Su Effects of leukotriene receptor antagonists on vascular endothelial growth factor and its receptors in a sensitized rat model Zhonghua Jie He He Hu Xi Za Zhi 32 2009 177 181
12. K. Takeda, Y. Shiraishi, S. Matsubara, N. Miyahara, H. Matsuda, and M. Okamoto Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation Br J Pharmacol 160 2010 1399 1407
13. A.M. Mohamadin, A.A. Elberry, M.A. Elkablawy, H.S. Gawad, and F.A. Al-Abbasi Montelukast, a leukotriene receptor antagonist abrogates lipopolysaccharide-induced toxicity and oxidative stress in rat liver Pathophysiol 18 2011 235 242
14. G.O. Dengiz, F. Odabasoglu, Z. Halici, E. Cadirci, and H. Suleyman Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats J Pharmacol Sci 105 2007 94 102 (Pubitemid 47469686)
15. M. Cuciureanu, I.D. Caruntu, M. Kuchar, and M. Nechifor The influence of leukotriene receptors' antagonists on experimentally induced ulcer in rats Rev Med Chir Soc Med Nat Iasi 112 2008 750 756
16. A. Beytur, E. Kose, M.E. Sarihan, H.I. Sapmaz, Z. Dogan, and A. Cetin Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats Ren Fail 34 2012 343 349
17. M.M. Helmy, and H.M. El-Gowelli Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production Eur J Pharmacol 15 2012 294 300
18. M. Kohan, A.F. Muro, R. Bader, and N. Berkman The extra domain A of fibronection is essential for allergen-induced airway fibrosis and hyperresponsiveness in mice J Allergy Clin Immunol 127 2011 439 446
19. A.B. Kay, S. Phipps, and D.S. Robinson A role for eosinophils in airway remodeling in asthma Trends Immunol 25 2004 477 482 (Pubitemid 39490254)
20. A. Mauviel Transforming growth factor beta: a key mediator of fibrosis Methods Mol Med 117 2005 69 80
21. A.Y. Wu, S.C. Chik, A.W. Chan, Z. Li, K.W. Tsang, and W. Li Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma Clin Exp Allergy 33 2003 359366
22. P.M. Krein, and B.W. Winston Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease Chest 122 2002 289S 293S (Pubitemid 36043015)
23. E. Lappi-Blanco, Y. Soini, V. Kinnula, and P. Paakko VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia J Pathol 196 2002 220 227 (Pubitemid 34110904)
24. N. Hamada, K. Kuwano, M. Yamada, N. Hagimoto, K. Hiasa, and K. Egashira Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice J Immunol 175 2005 1224 1231 (Pubitemid 41095011)
25. M. Hetzel, M. Bachem, D. Anders, G. Trischler, and M. Faehling Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblast Lung 183 2005 225 237 (Pubitemid 41428095)
26. A. Masamune, M. Satoh, K. Kikuta, N. Suzuki, and T. Shimosegawa Endothelin-1 stimulates contraction and migration of rat pancreatic stellate cells World J Gastroenterol 11 2005 6144 6151 (Pubitemid 43085056)
27. A. Moustakas, and C.H. Heldin The regulation of TGF-beta signal transduction Development 136 2009 3699 3714
28. W. Qin, A.C. Chung, X.R. Huang, X.M. Meng, D.S. Hui, and C.M. Yu TGF-{beta}/Smad3 signaling promotes renal fibrosis by inhibiting miR-29 J Am Soc Nephrol 22 2011 1462 1474
29. B. Wang, P. Koh, C. Winbanks, M.T. Coughlan, A. McClelland, and A. Watson miR-200a prevents renal fibrogenesis through repression of TGF-b2 expression Diabetes 60 2011 280 287
30. C.G. Lee, B. Ma, S. Takyar, F. Ahangari, C.H. He, and J.A. Elias Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease Proc Am Thorac Soc 8 2011 512 515
31. M.H. Muz, F. Deveci, Y. Bulut, N. Ilhan, H. Yekeler, and T. Turgut The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse model Exp Mol Med 38 2006 109 118 (Pubitemid 43764731)
32. W.R. Henderson Jr., G.K. Chiang, Y.T. Tien, and E.Y. Chi Reversal of allergen-induced airway remodeling by CysLT1 receptor blockage Am J Respir Crit Care Med 173 2006 718 728
33. A. Nayak, and R.B. Langdon Montelukast in the treatment of allergic rhinitis: an evidence-based review Drugs 67 2007 887 901 (Pubitemid 46607389)
34. K. Espinosa, Y. Bosse, J. Stankova, and M. Rola-Pleszczynski CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4 J Allergy Clin Immunol 111 2003 1032 1040 (Pubitemid 36570864)
35. Y. Bosse, C. Thompson, S. McMahon, C.M. Dubois, J. Stankova, and M. Rola-Pleszczynski Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation Clin Exp Allergy 38 2008 113 21 (Pubitemid 350233393)